Roxadustat downregulated the expression of angiotensin receptor 1, increased the expression of angiotensin receptor 2, eNOS and HIF1α protein levels, prevented Ang II-induced oxidative stress, eliminated hypertensive response, and prevented vascular thickening, myocardial hypertrophy and renal injury. Here, HIF1A is linked to cardiac hypertrophy.